tirzepatide with hypothyroidism and Tirzepatide & Hypothyroidism: Safety, Biomarkers

Its technically a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, producing greater effects than GLP-1-only medications

However, individual results vary significantly based on genetics, baseline metabolism, and adherence

I say this all the time to my clients You cant solve an emotional problem with a nutrition solution

Some studies suggest these compounds can boost GLP-1 release and improve insulin sensitivity, helping regulate appetite and blood sugar

Understanding your genetic predispositions helps PlexusDx personalize your treatment approach, potentially optimizing your dose strategy and medication choice for faster, more sustainable results